Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer.
Kessous R, Laskov I, Abitbol J, Bitharas J, Yasmeen A, Salvador S, Lau S, Gotlieb WH. Kessous R, et al. Among authors: abitbol j. Gynecol Oncol. 2017 Mar;144(3):474-479. doi: 10.1016/j.ygyno.2016.12.017. Epub 2016 Dec 29. Gynecol Oncol. 2017. PMID: 28041690
Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature.
Laskov I, Kessous R, Abitbol J, Kogan L, Badeghiesh A, Tagalakis V, Cohen S, Salvador S, Lau S, Gotlieb WH; SOGC Communities of Practice. Laskov I, et al. Among authors: abitbol j. J Obstet Gynaecol Can. 2018 Dec;40(12):1571-1579. doi: 10.1016/j.jogc.2018.04.003. Epub 2018 Sep 24. J Obstet Gynaecol Can. 2018. PMID: 30262383 Review.
Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
Kessous R, How J, Abitbol J, Puzhakkal S, Kogan L, Yasmeen A, Salvador S, Gotlieb WH, Lau S. Kessous R, et al. Among authors: abitbol j. Int J Gynecol Cancer. 2019 Sep;29(7):1121-1125. doi: 10.1136/ijgc-2019-000387. Epub 2019 Jul 17. Int J Gynecol Cancer. 2019. PMID: 31320490 Clinical Trial.
CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer.
Kessous R, Wissing MD, Piedimonte S, Abitbol J, Kogan L, Laskov I, Yasmeen A, Salvador S, Lau S, Gotlieb WH. Kessous R, et al. Among authors: abitbol j. Acta Obstet Gynecol Scand. 2020 Jul;99(7):933-940. doi: 10.1111/aogs.13814. Epub 2020 Feb 5. Acta Obstet Gynecol Scand. 2020. PMID: 31954071 Free article.
121 results